ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
질소 머스타드 시장 규모는 향후 수년간 강력한 성장이 전망될 예정입니다. 이러한 성장을 촉진하는 요인은 표적 암 치료에 대한 관심 증가, 종양학 연구 및 개발에 대한 투자 증가, 새로운 질소 머스타드 제제의 승인 증가, 신흥 시장에서 암 치료에 대한 접근성 확대, 맞춤형 의약품의 사용 증가 등입니다. 예측 기간에 예상되는 주요 동향으로는 의약품 전달 시스템의 발전, 효능 향상을 위한 제형 기술의 개선, 복합 화학요법의 혁신, 면역요법과의 통합, 전구 약물 개발 전략의 발전 등이 있습니다.
암의 유병률이 증가함에 따라 향후 몇 년 동안 질소 머스타드 시장이 성장할 것으로 예상됩니다. 암은 신체 내 비정상적인 세포의 무분별한 증식과 확산으로 특징지어지는 질병군입니다. 암 부담의 증가는 불균형한 식습관, 흡연, 신체 활동 부족, 과도한 알코올 섭취 등 생활 방식의 변화에 기인합니다. 질소 머스타드는 암 세포의 DNA에 작용해 복제를 차단함으로써 화학요법의 효과를 높여 종양 성장 억제에 기여합니다. 예를 들어, 2024년 7월 호주 보건 복지 연구소(Australian Institute of Health and Welfare)는 2022년 호주에서 진단된 암 환자 수가 16만 570명으로, 2021년 15만 6,781명 대비 3,789명 증가했다고 보고했습니다. 이처럼 암 발생률의 증가는 질소 머스타드 시장 확대에 기여하고 있습니다.
질소 머스타드 시장에서 활동하는 주요 기업들은 치료의 안전성과 사용 편의성을 개선하기 위해 즉시 희석 가능한 주사제 제형과 같은 첨단 의약품 전달 시스템의 개발에 주력하고 있습니다. 이러한 미리 조리된 액상 의약품은 직접 희석 및 투여할 수 있도록 설계되어 준비 과정을 간소화하고 투여 오류를 최소화합니다. 예를 들어, 2025년 5월, 캐나다에 본사를 둔 제약 회사인 Apotex Corp.는 IVRA (멜파란) 염산염 주사제 90mg/ml 다회용 바이알을 출시했습니다. 이 약물은 미국에서 505(b)(2) 신약 신청(NDA)에 따라 승인된 멜파란 주사제의 희석 준비가 된 액상 제형입니다. 이 알킬화제는 구강 치료가 불가능한 다발성 골수종 환자의 완화 치료를 목적으로 합니다. IVRA는 암 세포의 DNA에 알킬 그룹을 결합시켜 세포 복제를 방해하고 세포 사멸을 유발함으로써 종양 성장 억제에 도움을 줍니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 19 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 질소 머스타드 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 질소 머스타드 시장 : 성장률 분석
세계의 질소 머스타드 시장 실적 : 규모와 성장(2019-2024년)
세계의 질소 머스타드 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 질소 머스타드 : 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 질소 머스타드 시장 : 제품 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
메크로레타민
시클로포스파미드
이호스파미드
클로람부실
멜파란
기타 제품 유형
세계의 질소 머스타드 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
암 치료
자가면역질환
기타 용도
세계의 질소 머스타드 시장 : 유통 채널별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원
전문 클리닉
온라인 약국
기타 유통 채널
세계의 질소 머스타드 시장 : 메크로레타민 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
주사제
국소 제제
경구
세계의 질소 머스타드 시장 : 시클로포스파미드 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
정맥내(IV) 제제
경구
서방형 제제
세계의 질소 머스타드 시장 : 이포스파미드 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
정맥내 제형
병용 요법 제제
세계의 질소 머스타드 시장 : 클로람부실 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
경구
주사제
세계의 질소 머스타드 시장 : 멜파란 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
경구
정맥내 제형
주사용 분말
세계의 질소 머스타드 시장 : 기타 제품 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
경구
주사제
병용 요법 제제
제7장 지역별, 국가별 분석
세계의 질소 머스타드 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 질소 머스타드 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
질소 머스타드 시장 : 경쟁 구도
질소 머스타드 시장 : 기업 프로파일
Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Bristol-Myers Squibb Company : 개요, 제품 및 서비스, 전략 및 재무 분석
Merck & Co. Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Baxter International Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Fresenius Kabi AG : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Jiangsu Hengrui Medicine Co. Ltd.
Aurobindo Pharma Limited
Dr. Reddy's Laboratories Limited
Amneal Pharmaceuticals LLC
Zydus Cadila Healthcare Limited
Zhejiang Hisun Pharmaceutical Co. Ltd.
Shilpa Medicare Limited
Spectrum Chemical Manufacturing Corporation
Healthcare Advanced Synthesis
Apexbio Technology LLC
MSN Laboratories Private Limited
Actiza Pharmaceutical Private Limited
Emcure Pharmaceuticals Limited
InvivoChem LLC
NorthStar Rx LLC
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
질소 머스타드 시장(2029년) : 새로운 기회를 제공하는 국가
질소 머스타드 시장(2029년) : 새로운 기회를 제공하는 부문
질소 머스타드 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
HBR
영문 목차
영문목차
Nitrogen mustards are a category of bifunctional alkylating agents characterized by a nitrogen atom bonded to two 2-chloroethyl side chains (-N(CH2CH2Cl)2). This structure enables the formation of reactive aziridinium intermediates that covalently cross-link DNA strands, thereby disrupting replication and transcription. These compounds are utilized as chemotherapy drugs to treat various cancers by targeting and destroying rapidly dividing cancer cells.
The primary product types within the nitrogen mustards class include mechlorethamine, cyclophosphamide, ifosfamide, chlorambucil, melphalan, and others. Mechlorethamine, a nitrogen mustard alkylating chemotherapy agent, is mainly used for treating Hodgkin's lymphoma and certain skin cancers. These agents are employed in the treatment of cancer, autoimmune diseases, and other conditions, and are distributed through hospitals, specialty clinics, online pharmacies, and other channels.
The nitrogen mustards market research report is one of a series of new reports from The Business Research Company that provides nitrogen mustards market statistics, including the nitrogen mustards industry global market size, regional shares, competitors with the nitrogen mustards market share, detailed nitrogen mustards market segments, market trends, and opportunities, and any further data you may need to thrive in the nitrogen mustards industry. This nitrogen mustards market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The nitrogen mustards market size has grown strongly in recent years. It will grow from $3.30 billion in 2024 to $3.51 billion in 2025 at a compound annual growth rate (CAGR) of 6.2%. The historical growth is attributed to the rising prevalence of cancer, increasing demand for chemotherapy drugs, greater awareness of oncology treatments, higher healthcare expenditure, and the expanding use of combination therapies.
The nitrogen mustards market size is expected to see strong growth in the next few years. It will grow to $4.40 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. Factors driving this growth include a heightened focus on targeted cancer therapies, growing investments in oncology research and development, rising approvals of new nitrogen mustard formulations, broader access to cancer care in emerging markets, and increased use of personalized medicine. Key trends expected in the forecast period include advancements in drug delivery systems, enhanced formulation techniques for greater efficacy, innovations in combination chemotherapy, integration with immunotherapy, and progress in prodrug development strategies.
The increasing prevalence of cancer is expected to drive the growth of the nitrogen mustards market in the coming years. Cancer is a group of diseases marked by the uncontrolled growth and spread of abnormal cells in the body. The growing cancer burden is attributed to lifestyle choices such as poor diet, smoking, lack of physical activity, and excessive alcohol consumption. Nitrogen mustards are effective in cancer treatment as they interfere with the DNA of cancer cells, preventing their replication. This enhances the efficacy of chemotherapy by controlling and reducing tumor growth. For example, in July 2024, the Australian Institute of Health and Welfare, a government agency in Australia, reported that the number of cancer cases diagnosed in the country reached 160,570 in 2022, an increase of 3,789 cases from 156,781 in 2021. Thus, the rising incidence of cancer is contributing to the expansion of the nitrogen mustards market.
Major companies operating in the nitrogen mustards market are focusing on the development of advanced drug delivery systems, such as ready-to-dilute injectable formulations, to improve treatment safety and ease of use. These pre-prepared liquid drugs are designed for direct dilution and administration, streamlining the preparation process and minimizing dosing errors. For instance, in May 2025, Apotex Corp., a Canada-based pharmaceutical company, introduced IVRA (Melphalan) hydrochloride injection 90 mg/ml multidose vial-a ready-to-dilute liquid formulation of Melphalan injection approved under the 505(b)(2) new drug application (NDA) in the United States. This alkylating agent is intended for the palliative treatment of multiple myeloma patients who are not candidates for oral therapy. IVRA functions by binding alkyl groups to the DNA of cancer cells, thereby disrupting their replication and causing cell death, which helps control tumor growth.
In February 2022, Verity Pharmaceuticals International Ltd., a US-based pharmaceutical company, entered into a partnership with Helsinn Therapeutics Inc. to promote Akynzeo and Valchlor in Puerto Rico. This collaboration aims to capitalize on Verity's strong local presence and knowledge to improve market access and raise awareness of these oncology treatments, thereby enhancing patient support and accessibility in the Puerto Rico region. Helsinn Therapeutics Inc. is a US-based pharmaceutical firm that develops nitrogen mustard-based oncology therapies, including Valchlor.
Major players in the nitrogen mustards market are Pfizer Inc., Bristol-Myers Squibb Company, Merck & Co. Inc., Baxter International Inc., Fresenius Kabi AG, Jiangsu Hengrui Medicine Co. Ltd., Aurobindo Pharma Limited, Dr. Reddy's Laboratories Limited, Amneal Pharmaceuticals LLC, Zydus Cadila Healthcare Limited, Zhejiang Hisun Pharmaceutical Co. Ltd., Shilpa Medicare Limited, Spectrum Chemical Manufacturing Corporation, Healthcare Advanced Synthesis, Apexbio Technology LLC, MSN Laboratories Private Limited, Actiza Pharmaceutical Private Limited, Emcure Pharmaceuticals Limited, InvivoChem LLC, NorthStar Rx LLC, ChemNet Group Limited, Saintroy Lifescience.
North America was the largest region in the nitrogen mustards market in 2024. The regions covered in nitrogen mustards report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the nitrogen mustards market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The nitrogen mustards market consists of sales of bendamustine, uracil mustard, tretamine, and perfosfamide. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Nitrogen Mustards Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on nitrogen mustards market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for nitrogen mustards ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The nitrogen mustards market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product Type: Mechlorethamine; Cyclophosphamide; Ifosfamide; Chlorambucil; Melphalan; Other Product Types
2) By Application: Cancer Treatment; Autoimmune Diseases; Other Applications
3) By Distribution Channel: Hospitals; Specialty Clinics; Online Pharmacies; Other Distribution Channels
Subsegments:
1) By Mechlorethamine: Injectable Formulation; Topical Formulation; Oral Formulation
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Nitrogen Mustards Market Characteristics
3. Nitrogen Mustards Market Trends And Strategies
4. Nitrogen Mustards Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Nitrogen Mustards Growth Analysis And Strategic Analysis Framework
5.1. Global Nitrogen Mustards PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Nitrogen Mustards Market Growth Rate Analysis
5.4. Global Nitrogen Mustards Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Nitrogen Mustards Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Nitrogen Mustards Total Addressable Market (TAM)
6. Nitrogen Mustards Market Segmentation
6.1. Global Nitrogen Mustards Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mechlorethamine
Cyclophosphamide
Ifosfamide
Chlorambucil
Melphalan
Other Product Types
6.2. Global Nitrogen Mustards Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cancer Treatment
Autoimmune Diseases
Other Applications
6.3. Global Nitrogen Mustards Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Specialty Clinics
Online Pharmacies
Other Distribution Channels
6.4. Global Nitrogen Mustards Market, Sub-Segmentation Of Mechlorethamine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Injectable Formulation
Topical Formulation
Oral Formulation
6.5. Global Nitrogen Mustards Market, Sub-Segmentation Of Cyclophosphamide, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Intravenous (IV) Formulation
Oral Tablets
Extended Release Formulation
6.6. Global Nitrogen Mustards Market, Sub-Segmentation Of Ifosfamide, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Intravenous Formulation
Combination Therapy Formulation
6.7. Global Nitrogen Mustards Market, Sub-Segmentation Of Chlorambucil, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Tablets
Injectable Formulation
6.8. Global Nitrogen Mustards Market, Sub-Segmentation Of Melphalan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Formulation
Intravenous Formulation
Powder for Injection
6.9. Global Nitrogen Mustards Market, Sub-Segmentation Of Other Product Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Formulation
Injectable Formulation
Combination Therapy Formulation
7. Nitrogen Mustards Market Regional And Country Analysis
7.1. Global Nitrogen Mustards Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Nitrogen Mustards Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
